Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.
about
Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolitesInhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cellsArsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro.Synergistic apoptosis of CML cells by buthionine sulfoximine and hydroxychavicol correlates with activation of AIF and GSH-ROS-JNK-ERK-iNOS pathway.Regulation of apoptosis in human melanoma and neuroblastoma cells by statins, sodium arsenite and TRAIL: a role of combined treatment versus monotherapy.Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival.Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death.Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.Suppression of the proinflammatory response of metastatic melanoma cells increases TRAIL-induced apoptosisLymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest.Biological responses to arsenic compoundsThe PTEN-AKT3 signaling cascade as a therapeutic target in melanoma.Melanocytes and keratinocytes have distinct and shared responses to ultraviolet radiation and arsenic.2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-κB, AP-1 and MAPK pathways in human proximal tubular cells.Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.U937 cell apoptosis induced by arsenite is prevented by low concentrations of mitochondrial ascorbic acid with hardly any effect mediated by the cytosolic fraction of the vitamin.Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression.Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.Anion exchanger 2 mediates the action of arsenic trioxide.Radiation-induced bystander signaling pathways in human fibroblasts: a role for interleukin-33 in the signal transmission.Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells.Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma.Sodium arsenite exposure inhibits AKT and Stat3 activation, suppresses self-renewal and induces apoptotic death of embryonic stem cells.Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses.
P2860
Q25256850-92BDBE28-7E7B-4FA3-8E41-FD69650BE898Q33803816-1E385576-C5F9-4B38-B1C7-BBAC41E92399Q34185125-41738C37-8B2E-43B7-B9BA-332D88760D36Q34989086-FACBB8EA-06E3-4FBB-A60F-0D2FDDA59776Q35213333-BF60E0F8-8695-4F0B-9BAC-661B00A89D5AQ35218738-6D4A818F-89D7-4670-B4F6-4F806161A468Q35226559-735919C9-2D0C-4ED0-A376-BAAD666200ADQ35229797-C78B7214-CE92-4110-9FF8-30DAD46731F4Q35230726-28B10A51-FBCD-49F9-AC95-196676A4FFEFQ36453943-17F50FAB-E999-4531-B2DA-3F583CB7773BQ36775161-F7725C5A-3FB1-4283-8AE5-A44AF61DFAF1Q37442397-72EB33B8-5AEB-491F-BA04-3C9D3AB2DCD6Q37506648-269B57DC-0C4C-4571-A0EE-FC7645194B87Q37633714-5F0A1487-5D60-481B-8045-6426CF561396Q38832666-0DBD8C9A-351D-4F8F-A7E7-EF8372EEA51DQ38877894-52579100-092E-4897-9352-5C74684D97C8Q38895083-4128E71D-6F1E-424E-B9C5-996E396344E9Q39559565-00C7D033-772B-487D-9AF2-864DA91948D6Q40020341-801B6431-ED0E-4A14-AFAF-1E5AD2502C26Q40214713-DC8E5535-C7DF-4299-A678-EDD60EAE6E39Q40224250-B52A4DFE-7ADB-4E46-A44B-C4E7BE847541Q40230575-CC8F0BEF-2692-41D9-BBFE-2483070AC70BQ40314772-FFAD32EA-8278-4B45-AC77-74F576C434F1Q40822940-1E68B1BB-57A6-4499-849C-F35B5CD8BB94Q41891670-73A7833A-546F-4E48-8341-7B741366ACCAQ53599319-E2B7E212-676A-47D9-ACDC-79D598B8ABB5
P2860
Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@ast
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@en
type
label
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@ast
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@en
prefLabel
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@ast
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@en
P2860
P356
P1476
Arsenite sensitizes human mela ...... factor alpha-mediated pathway.
@en
P2093
Vladimir N Ivanov
P2860
P304
22747-22758
P356
10.1074/JBC.M314131200
P407
P577
2004-03-17T00:00:00Z